Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06783621 · ClinicalTrials.gov registry record · Phase 4
A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of OnabotulinumtoxinA, JUVÉDERM® Products, KYBELLA, CoolSculpting Elite and SkinMedica Products
A Phase 4 study of Facial Contouring, sponsored by AbbVie.
- Active
- Registry status
- Phase 4
- Development phase
- 130
- Enrollment target
- 10
- Study locations
NCT06783621 is a Phase 4 study of Facial Contouring that is active but no longer recruiting, run by AbbVie. The registered enrollment target is 130 participants. The trial reports 10 study locations across 8 states.
The verdict
NCT06783621, a Phase 4 study of Facial Contouring, is active but no longer recruiting, sponsored by AbbVie.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 130 participants
- Enrollment target
- 10
- Study locations
Study Summary
A study to evaluate overall participant satisfaction of face and neck appearance after treatment with onabotulinumtoxinA, JUVÉDERM® products, KYBELLA, CoolSculpting Elite, and select SkinMedica products in a diverse population.
Conditions Studied
Interventions
- DRUG OnabotulinumtoxinA
- DEVICE CoolSculpting Elite System
- DEVICE JUVÉDERM
- OTHER SkinMedica Products
- DRUG KYBELLA
Study Locations (10)
California
- Marcus Facial Plastic Surgery /ID# 270408 - Redondo Beach
- Pacific Clinical Innovations /ID# 270414 - Vista
Texas
- Bellaire Dermatology Associates /ID# 270429 - Bellaire
- Integrated Aesthetics /ID# 270399 - Spring
District of Columbia
- Center for Dermatology and Dermatologic Surgery /ID# 270390 - Washington D.C.
Florida
- Skin Research Institute LLC /ID# 270410 - Coral Gables
Louisiana
- DelRicht Research - New Orleans 308 /ID# 270425 - New Orleans
Michigan
- Boyd /Id# 270509 - Birmingham
New York
- Luxurgery /ID# 270430 - New York
Virginia
- SkinDC /ID# 270411 - Arlington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2025-01-16 |
| Est. Completion | 2026-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06783621
The ClinicalTrials.gov registry entry for NCT06783621 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AbbVie, which has 526 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Facial Contouring appearing as the primary indexed condition, and to 5 interventions - of which OnabotulinumtoxinA is the first listed.
NCT06783621 reports 10 study locations spanning 8 distinct geographic areas - top geographies include California, Texas, District of Columbia.
Frequently Asked Questions
What is clinical trial NCT06783621 about?
NCT06783621 is a clinical study titled "A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of OnabotulinumtoxinA, JUVÉDERM® Products, KYBELLA, CoolSculpting Elite and SkinMedica Products". A study to evaluate overall participant satisfaction of face and neck appearance after treatment with onabotulinumtoxinA, JUVÉDERM® products, KYBELLA, CoolSculpting Elite, and select SkinMedica products in a diverse population.
What is the current status of trial NCT06783621?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 130 participants. The study started on 2025-01-16. Estimated completion is 2026-03.
What conditions does trial NCT06783621 study?
This clinical trial studies the following conditions: Facial Contouring.
What interventions are being tested in trial NCT06783621?
The interventions under investigation include: OnabotulinumtoxinA (DRUG), CoolSculpting Elite System (DEVICE), JUVÉDERM (DEVICE), SkinMedica Products (OTHER), KYBELLA (DRUG).
Who is sponsoring clinical trial NCT06783621?
This trial is sponsored by AbbVie, which has 526 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06783621 being conducted?
This trial has 10 study locations across California, District of Columbia, Florida, Louisiana, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.